Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Discover the latest updates in breast cancer clinical practice and research from leading experts at the 18th St. Gallen International Breast Cancer Conference 2023 featuring key topics in early breast cancer, including immunology, the role of genomics for disease monitoring and risk stratification, as well as the anticipated St. Gallen International Consensus Session.

BCC 2023

18th St.Gallen International Breast Cancer Conference 2023
15–18 March 2023 | Vienna, Austria

Today is International Women's Day and we are joining the campaign to #InspireInclusion πŸ’™

We'd like to thank all of the incredible women on our editorial board and within this field, who work hard to make a difference πŸ‘©β€βš•οΈπŸ©Ί

#IWD2024

As March is #myelomaawarenessmonth, we wanted to share an update from the 20th International Myeloma Society (IMS) Annual Meeting | The value of #circulating #tumor cells for the staging of patients with #NDMM @BrunoPaiva_UNAV πŸ“£πŸ©Έ

πŸ‘‰ https://www.vjhemonc.com/video/vhnenc6jsa-the-value-of-circulating-tumor-cells-for-the-staging-of-patients-with-ndmm/

#VJHemOnc #MMsm

March is #prostatecancer awareness month and what better time to hear about the latest in prostate cancer therapies?

We have updates from the Phase II #BRCAAway trial, demonstrating the benefits of #combinationtherapy over #sequentialtherapy πŸ”¦πŸŽ₯

πŸ‘‰ https://www.vjoncology.com/video/k0etnzlaq1c-brcaaway-abiraterone-with-olaparib-in-mcrpc-with-hrr-mutations/

Load More

BCC 2023

18th St.Gallen International Breast Cancer Conference 2023
15–18 March 2023 | Vienna, Austria
Discover the latest updates in breast cancer clinical practice and research from leading experts at the 18th St. Gallen International Breast Cancer Conference 2023 featuring key topics in early breast cancer, including immunology, the role of genomics for disease monitoring and risk stratification, as well as the anticipated St. Gallen International Consensus Session.

Today is International Women's Day and we are joining the campaign to #InspireInclusion πŸ’™

We'd like to thank all of the incredible women on our editorial board and within this field, who work hard to make a difference πŸ‘©β€βš•οΈπŸ©Ί

#IWD2024

As March is #myelomaawarenessmonth, we wanted to share an update from the 20th International Myeloma Society (IMS) Annual Meeting | The value of #circulating #tumor cells for the staging of patients with #NDMM @BrunoPaiva_UNAV πŸ“£πŸ©Έ

πŸ‘‰ https://www.vjhemonc.com/video/vhnenc6jsa-the-value-of-circulating-tumor-cells-for-the-staging-of-patients-with-ndmm/

#VJHemOnc #MMsm

March is #prostatecancer awareness month and what better time to hear about the latest in prostate cancer therapies?

We have updates from the Phase II #BRCAAway trial, demonstrating the benefits of #combinationtherapy over #sequentialtherapy πŸ”¦πŸŽ₯

πŸ‘‰ https://www.vjoncology.com/video/k0etnzlaq1c-brcaaway-abiraterone-with-olaparib-in-mcrpc-with-hrr-mutations/

Load More